Form 4: Amedisys Inc. Chief Accounting Officer Reports Stock Transaction
SEC Form 4 Filing
Allyson Guidroz, Chief Accounting Officer of Amedisys Inc., reports a transaction involving common stock on June 1, 2024.
Summary
- On June 1, 2024, Allyson Guidroz, Chief Accounting Officer of Amedisys Inc., reported a transaction involving the company's common stock.
- The transaction involved the disposal of 175 shares of common stock at a price of $91.15 per share.
- Following the transaction, Guidroz directly owns 6,819 shares of Amedisys Inc. common stock.
- Guidroz also indirectly owns 1.5 shares of common stock through a 401(k) plan, based on a plan statement dated March 31, 2024.
Sentiment
Score: 5
Explanation: This is a routine disclosure of a stock transaction by a company officer, and does not inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It's a standard practice for officers of publicly traded companies.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders, as it involves a relatively small number of shares disposed of by a single officer.
Key Dates
| Date | Description |
|---|---|
| 2024-03-31 | Date of the 401(k) plan statement used for reporting indirect ownership. |
| 2024-06-01 | Date of the stock transaction (disposal of shares). |
| 2024-06-04 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.